APOA5 and triple-A syndrome: Hyperlipidemic mice overexpressing Apoa5 have been shown to have markedly decreased circulating remnant lipoprotein particles36,37, and individuals with rare protein-altering variants in APOA5 were observed to have increased levels of remnant cholesterol38, providing further evidence of the effects of remnant cholesterol on AAA risk.